drugset
drugset / Trial / NCT02819934

A Phase I Study to Investigate the ADME of KD101

NCT02819934 ↗

Phase 1 Completed 6 enrolled Seoul National University Hospital
NaSingle-groupOpen-labelBasic science

Summary

A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of KD101 in Male Subjects

Timeline

Start
2016-05-20
Primary completion
2016-06-06
Completion
2018-12-15

Drugs

EvaluationDrugModalityDoseRoute
Subject KD101 Unknown 3.52 ug Oral

Indications

obesity disorder